Prognosis of Guillain-Barré syndrome in the African: the Nigerian experience.
Autor(es): Osuntokun B O,Agbebi K
Resumo: The clinical features of the Guillain-Barré syndrome in 34 Nigerian patients are reported. The patients were treated with oral prednisolone 20 mg three times daily for a minimum of six weeks. Twenty-seven patients recovered completely and five others showed considerable improvement, although three of them appeared to be `steroid dependent'. Two patients died. The good prognosis and the response to treatment with prednisolone in this series is in keeping with an allergic demyelinating neuropathy.
Imprenta: Journal of Neurology, Neurosurgery, and Psychiatry, v. 36, n. 3, p. 478-483, 1973
Identificador do objeto digital: 10.1136/jnnp.36.3.478
Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Epidemiology ; Guillain-Barre Syndrome - Public health
Data de publicação: 1973
